Skip to main content

Cartilage Regeneration Market | Analysis and Business Opportunities of Revenue Generating Industry Segments

Increase in obese population and rising incidence of sports injuries are the major factors driving the demand of cartilage regeneration. On the other hand, high cost of therapy and unfavorable reimbursement scenario are the major factors restraining the growth of cartilage regeneration market.

What the market looks like?

The
cartilage regeneration market is projected to reach USD 779.8 Million by 2021 from USD 414.6 Million in 2016, growing at a CAGR of 13.5%.

Treatment Modalities Segment:

Based on treatment modalities, the market is segmented into cell based approaches and non-cell based approaches. Cell based approaches are further segmented into chondrocyte transplantation, growth factor technology, and stem cells. Non-cell based approaches are segmented into tissue scaffolds and cell-free composites. The cell based approaches segment is expected to account for the largest market share.

This treatment modality segment is also expected to be the fastest growing segment in the cartilage repair/ cartilage regeneration market. This segment is projected to grow at CAGR of 14.1% during forecast period.

Applications of Cartilage Regeneration Market:

On the basis of applications, the cartilage repair/ cartilage regeneration market is segmented into hyaline cartilage and fibrocartilage. Among this segments, the hyaline cartilage segment is expected to account for the largest market share in 2016. Hyaline cartilage application segment is also expected to be the fastest growing application segment in the cartilage repair/ cartilage regeneration market. This application segment is projected to grow at CAGR of 13.9% during forecast period. The large share and high growth of this segment can be attributed to the high prevalence of cartilage damage in hyaline cartilage.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=37493272

Regional Growth Analysis:

North America is expected to be the fastest-growing regional segment in the cartilage repair/ cartilage regeneration market. North America is also expected to account for largest share in the cartilage repair/ cartilage regeneration market, by region in 2016. The high growth and largest share of this segment can primarily be attributed to the expansion of the cartilage repair/ cartilage regeneration market in this region due to presence of major players in this market and wide availability of cartilage repair products.

Key Players in Cartilage Regeneration Market:

The major players operating in the cartilage repair/ cartilage regeneration market include Zimmer Biomet Holdings, Inc. (U.S.), Vericel Corporation (U.S.), Smith & Nephew plc (U.K.), Osiris Therapeutics, Inc. (U.S.), and Arthrex Inc. (U.S.).

Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=37493272

A combination of bottom-up and top-down approaches was used to calculate the market sizes and growth rates of the global cartilage repair/ cartilage regeneration market and its sub segments. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Comments

Popular posts from this blog

NGS-Based RNA-Sequencing Industry is Growing at a CAGR of 20%

NGS-based RNA-sequencing Market growth is driven mainly by the advantages of RNA-seq over conventional technologies; an increasing number of RNA-seq grants; rising number of research activities involving RNA-seq; and rapid growth in precision medicine market. NGS-based RNA-sequencing Market: Impact Analysis 1. NGS-Based RNA-Sequencing: Market Overview 2. Geographical Snapshot of the NGS-Based RNA-Sequencing Market 3. Rapid Growth in Precision Medicine 4. Growing Number of Research Activities Involving RNA-Seq 5. Increasing Applications of RNA-Seq in Research ( Cancer and Agricultural) The NGS-based RNA-sequencing market size is estimated to grow from USD 1.7 billion in 2019 to USD 4.2 billion by 2024, at a CAGR of 20.0%. Key Questions Addressed in The Report: 1. Who are the top 10 players operating in the global NGS-based RNA-sequencing market? 2. What are the drivers, restraints, opportunities, and challenges in the NGS-based RNA-sequencing Industry? 3. What are th...

Digital Diabetes Management Market to Reach $19.98 billion by 2024 | Market and Regional Growth Analysis

  Digital diabetes management solutions are smartphone-connected diabetes management devices and software platforms used by patients suffering from Type 1, Type 2, and gestational diabetes. Medical professionals also use these solutions to manage diabetes. Various digital diabetes management devices such as smart glucose meters, continuous glucose monitoring systems, smart insulin pens, and smart insulin pumps/closed-loop systems and smart insulin patches are used for glucose monitoring and insulin delivery. Diabetes management applications, data management software & platforms, and services are used by patients and healthcare providers for remote monitoring, data analysis, and disease management. The Digital Diabetes Management Market is experiencing significant growth due to rising prevalence of diabetes has increased the focus on the development and adoption of better solutions for diabetes care. Also, advancements in technologies have ensured the introduction of highly...

Epigenetics Market | Major Market Dynamics Impacting The Global Industry

Epigenetics refers to the covalent modification of DNA, RNA, or protein that results in changes to the function and/or regulation of these molecules, without altering their primary sequences. These modifications can occur naturally, or can be influenced, by several factors including age, environment, disease state, and changes in lifestyle. Expanding application areas of epigenetics in non-oncology diseases, personalized medicine, and target therapy are expected to provide growth opportunities for players operating in the epigenetics market in the coming years. The growth in this market is primarily attributed to decreasing sequencing costs, increasing research activity, funding for epigenetics research, rising prevalence of cancer and growing applications of epigenetics in non-oncology diseases. Epigenetic changes such as dysregulation of DNA methylation are associated with cancer development and progression. Epigenetics provides new opportunities for deriving therapeutic strateg...